Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript

TheMotleyFool 
0 0 02.08.24
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call TranscriptPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
 

Image source: The Motley Fool.

Vertex Pharmaceuticals (NASDAQ: VRTX)
Q2 2024 Earnings Call
Aug 01, 2024, 4:30 p.m. ET

Operator

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€413.65
-1.050%
We can see a decrease in the price for Vertex Pharmaceuticals Inc.. Compared to yesterday it has lost -€4.400 (-1.050%).
With 47 Buy predictions and 1 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 467 € shows a slightly positive potential of 12.9% compared to the current price of 413.65 € for Vertex Pharmaceuticals Inc..
Show more
Like: 0
VRTX
Share

Comments

Not a member yet? Sign up for free!